ClinVar Miner

Submissions for variant NM_000346.4(SOX9):c.508C>G (p.Pro170Ala)

dbSNP: rs866706988
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 4
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Institute of Medical Genetics and Applied Genomics, University Hospital Tübingen RCV001291597 SCV001480146 likely pathogenic not provided 2021-02-01 criteria provided, single submitter clinical testing
Baylor Genetics RCV001329809 SCV001521346 likely pathogenic Camptomelic dysplasia criteria provided, single submitter clinical testing
Institute of Human Genetics, Heidelberg University RCV001329809 SCV001739384 pathogenic Camptomelic dysplasia 2021-04-21 criteria provided, single submitter clinical testing The variant was not found in DNA extracted from the parents' blood samples (PS2), the variant is absent from controls (gnomAD; PM2), multiple lines of computational evidence support a deleterious effect (PP3) and it is localized at an amino acid site where different missense changes determined to be pathogenic have been seen before (PM5); therefore we classified it as pathogenic according to ACMG criteria.
Invitae RCV001329809 SCV002259073 likely pathogenic Camptomelic dysplasia 2022-06-20 criteria provided, single submitter clinical testing In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. This variant disrupts the p.Pro170 amino acid residue in SOX9. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 9002675). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt SOX9 protein function. ClinVar contains an entry for this variant (Variation ID: 996802). This variant has not been reported in the literature in individuals affected with SOX9-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change replaces proline, which is neutral and non-polar, with alanine, which is neutral and non-polar, at codon 170 of the SOX9 protein (p.Pro170Ala).

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.